LABCORP HOLDINGS INC (LH)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for LH
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| LH | Managing Partner | 50 | ["Managing Partner, HealthQuest Capital"] | ["CHAIR"] | 2026 |
Biography sourced from the proxy statement filing.
Garheng Kong has served as a director of the Company since December 2013, Lead Independent Director since June 2023, and Vice Chairman of the Board since December 2025. Dr. Kong also serves as the Chair of the Nominating and Corporate Governance Committee for the Company. Dr. Kong is the managing partner of HealthQuest Capital, a healthcare-focused investment firm, a role he has held since he founded HealthQuest Capital in 2012. He was previously a general partner at Sofinnova Capital, a position he held from 2010 to 2013. Before joining Sofinnova, Dr. Kong was a general partner from 2000 to 2010 at Intersouth Partners, a venture capital firm, where he was a founding investor or board member for various life science ventures, several of which were acquired by large pharmaceutical companies. Prior to his investing career, Dr. Kong was employed by GlaxoSmithKline, McKinsey & Company, and TherOx. Dr. Kong received undergraduate degrees in both Chemical Engineering and Biological Sciences from Stanford, and earned a Doctor of Medicine, and Doctor of Philosophy and Master of Business Administration from Duke University. Skills and Qualifications: Knowledge and experience in both the healthcare and finance fields Executive leadership experience Life science-related venture capital experience Corporate governance expertise through service on public company boards Committees: Compensation and Human Capital Committee Nominating and Corporate Governance Committee (Chair) Current Public Company Board Experience: Smith & Nephew plc IKS Health (NSE:IKS) Lunit Inc. (KOSDAQ: 328130) Xeris Biopharma Holdings, Inc. (formerly Strongbridge Biopharma plc) Previous Public Company Board Experience: Venus Concept Inc. Histogenics Corporation Avedro, Inc. Melinta Therapeutics, Inc. Alimera Sciences, Inc. Other Current Relevant Experiences: Duke University Health System UT Medicine Dell Children s Foundation, Board of Trustees Austin Healthcare Council Business Strategy Corporate Finance and M&A Corporate Governance Executive Leadership Healthcare/ Clinical Research Risk Management Talent Management